2025年6月11日 周三
Home > Archive>Volume 30, Issue 3, 2022 >260-264
PDF HTML XML Export Cite reminder
Diagnostic value and prospect of MBF and CFR measured by radionuclide myocardial imaging in coronary heart disease
Author:
Affiliation:

Nuclear Medicine Department, People's Hospital of Liaoning Provincial, Shenyang, Liaoning 110000, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference [41]
    • | | | |
  • Comments
    Abstract:

    Cardiovascular disease is the leading cause of death in the world. The economic cost of treatment and diagnosis is very high. In the past two decades, the diagnosis, treatment and evaluation of patients with coronary heart disease have undergone various changes. Positron emission tomography is a powerful and multi-functional noninvasive imaging examination, especially by quantifying the myocardial blood flow and coronary flow reserve, it can better describe the characteristics of coronary artery disease, play an important role in the early diagnosis, classification and treatment of coronary microvascular disease and ischemic cardiomyopathy.

    Reference
    [1] MANABE O, NAYA M, TAMAKI N.Feasibility of PET for the management of coronary artery disease:comparison between CFR and FFR.J Cardiol, 7,0(2):135-140.
    [2] 籍庆余.冠状动脉微血管疾病的影像学研究进展.中国心血管病研究, 8,6(3):197-201.
    [3] 张运, 陈韵岱, 傅向华, 等.冠状动脉微血管疾病诊断和治疗的中国专家共识.中国循环杂志, 7,2(5):421-430.
    [4] DRIESSEN R S, RAIJMAKERS P G, STUIJFZAND W J, et al.Myocardial perfusion imaging with PET.Int J Cardiovasc Imaging, 7,3(7):1021-1031.
    [5] SARASTE A, KNUUTI J.PET imaging in heart failure:the role of new tracers.Heart Fail Rev, 7,2(4):501-511.
    [6] PELLETIER-GALARNEAU M, MARTINEAU P, EL F G.Quantification of PET myocardial blood flow.Curr Cardiol Rep, 9,1(3):11-13.
    [7] WESTERGREN H U, MICHALSSON E, BLOMSTER J I, et al.Determinants of coronary flow reserve in non-diabetic patients with chest pain without myocardial perfusion defects.PLoS One, 7,2(4):e0176511.
    [8] GOULD K L, JOHNSON N P, ROBY A E, et al.Regional, artery-specific thresholds of quantitative myocardial perfusion by PET associated with reduced myocardial infarction and death after revascularization in stable coronary artery disease.J Nucl Med, 9,0(3):410-417.
    [9] PATEL K K, SPERTUS J A, CHAN P S, et al.Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization.Eur Heart J, 0,1(6):759-768.
    [10] ONG P, CAMICI P G, BELTRAME J F, et al.International standardization of diagnostic criteria for microvascular angina.Int J Cardiol, 8,0:16-20.
    [11] BOER J J, KAPPELHOF J, VAN DER ZANT F M, et al.13N-ammonia PET/CT stress myocardial blood flow compared to fractional flow reserve in coronary artery disease.Nucl Med Commun, 0,1(2):133-138.
    [12] GEWIRTZ H.PET 18F-flurpridaz quantitative measurements of myocardial blood flow:added value for diagnosis of coronary artery disease? Of course!.J Nucl Cardiol, 2020.DOI:10.1007/s12350-020-02043-1.
    [13] BOM M J, VAN DIEMEN P A, DRIESSEN R S, et al.Prognostic value of [15O]H2O positron emission tomography-derived global and regional myocardial perfusion.Eur Heart J Cardiovasc Imaging, 0,1(7):777-786.
    [14] GUPTA A, TAQUETI V R, VAN D T, et al.Integrated noninvasive physiological assessment of coronary circulatory function and impact on cardiovascular mortality in patients with stable coronary artery disease.Circulation, 7,6(24):2325-2336.
    [15] DUNCKER D J, KOLLER A, MERKUS D, et al.Regulation of coronary blood flow in health and ischemic heart disease.Prog Cardiovasc Dis, 5,7(5):409-422.
    [16] 王晓阳, 秦纲.冠状动脉血流储备与冠状动脉微血管疾病的研究进展.中国动脉硬化杂志, 0,8(8):728-732.
    [17] BRAININ P, FRESTAD D, PRESCOTT E.The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease:a systematic review and Meta-analysis.Int J Cardiol, 8,4:1-9.
    [18] 武萍, 郭小闪, 张茜, 等.PET心肌血流绝对定量评估冠状动脉微血管疾病的临床研究.中华心血管病杂志, 0,8(3):205-210.
    [19] 盖婉丽, 武萍, 梁云亮, 等.PET心肌血流绝对定量对非阻塞性冠状动脉微血管疾病的诊断及危险因素评估.中华核医学与分子影像杂志, 9,9(8):478-483.
    [20] GOULD K L, JOHNSON N P.Coronary physiology beyond coronary flow reserve in microvascular angina:JACC state-of-the-art review.J Am Coll Cardiol, 8,2(21):2642-2662.
    [21] SCHINDLER T H, DILSIZIAN V.Coronary microvascular dysfunction:clinical considerations and noninvasive diagnosis.JACC Cardiovasc Imaging, 0,3(1 Pt 1):140-155.
    [22] AZIZ A, HANSEN H S, SECHTEM U, et al.Sex-related differences in vasomotor function in patients with angina and unobstructed coronary arteries.J Am Coll Cardiol, 7,0(19):2349-2358.
    [23] SARA J D, WIDMER R J, MATSUZAWA Y, et al.Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease.JACC Cardiovasc Interv, 5,8(11):1445-1453.
    [24] MURTHY V L, BATEMAN T M, BEANLANDS R S, et al.Correction to:clinical quantification of myocardial blood flow using PET:joint position paper of the SNMMI cardiovascular council and the ASNC.J Nucl Cardiol, 8,5(6):2189-2190.
    [25] GEWIRTZ H, DILSIZIAN V.Integration of quantitative positron emission tomography absolute myocardial blood flow measurements in the clinical management of coronary artery disease.Circulation, 6,3(22):2180-2196.
    [26] NISHI T, MURAI T, CICCARELLI G, et al.Prognostic value of coronary microvascular function measured immediately after percutaneous coronary intervention in stable coronary artery disease:an international multicenter study.Circ Cardiovasc Interv, 9,2(9):e007889.
    [27] MARINESCU M, LFFLER A I, OUELLETTE M, et al.Coronary microvascular dysfunction, microvascular angina, and treatment strategies.JACC Cardiovasc Imaging, 5,8(2):210-220.
    [28] WESTERGREN H U, MICHALSSON E, BLOMSTER J I, et al.Determinants of coronary flow reserve in non-diabetic patients with chest pain with out myocardial perfusion defects.PLoS One, 7,2(4):e0176511.
    [29] MAJMUDAR M D, MURTHY V L, SHAH R V, et al.Quantification of coronary flow reserve in patients with ischaemic and non-ischemic cardiomyopathy and its association with clinical outcomes.Eur Heart J Cardiovasc Imaging, 5,6(8):900-909.
    [30] SCIAGR R, CALABRETTA R, CIPOLLINI F, et al.Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy:a 13NH3 gated PET study.Eur J Nucl Med Mol Imaging, 7,4(5):866-875.
    [31] KAJANDER S, JOUTSINIEMI E, SARASTE M, et al.Clinical value of absolute quantification of myocardial perfusion with 15O-water in coronary artery disease.Circ Cardiovasc Imaging, 1,4(6):678-684.
    [32] FIECHTER M, GHADRI J R, GEBHARD C, et al.Diagnostic value of 13N-ammonia myocardial perfusion PET:added value of myocardial flow reserve.J Nucl Med, 2,3(8):1230-1234.
    [33] TAQUETI V R, EVERETT B M, MURTHY V L, et al.Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.Circulation, 5,1(6):528-535.
    [34] TAQUETI V R, SOLOMON S D, SHAH A M, et al.Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.Eur Heart J, 8,9(10):840-849.
    [35] PAZ Y, MORGENSTERN R, WEINBERG R, et al.Relation of coronary flow reserve to other findings on positron emission tomography myocardial perfusion imaging and left heart catheterization in patients with end-stage renal disease being evaluated for kidney transplant.Am J Cardiol, 7,0(11):1909-1912.
    [36] PHILLIPS L M.CZT-SPECT:reaching its potential.JACC Cardiovasc Imaging, 7,0(7):795-796.
    [37] MIYAGAWA M, NISHIYAMA Y, UETANI T, et al.Estimation of myocardial flow reserve utilizing an ultrafast cardiac SPECT:comparison with coronary angiography, fractional flow reserve, and the SYNTAX score.Int J Cardiol, 7,4:347-353.
    [38] AGOSTINI D, ROULE V, NGANOA C, et al.First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera:head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease.The WATERDAY study.Eur J Nucl Med Mol Imaging, 8,5(7):1079-1090.
    [39] SHIRAISHI S, TSUDA N, SAKAMOTO F, et al.Clinical usefulness of quantification of myocardial blood flow and flow reserve using CZT-SPECT for detecting coronary artery disease in patients with normal stress perfusion imaging.J Cardiol, 0,5(4):400-409.
    [40] GLENN W R, IVANA R P, DUNCAN C B, et al.Test-retest precision of myocardial blood flow measurements with 99mTc-Tetrofosmin and solid state detector single photon emission computed tomography.Circ Cardiovasc Imaging, 0,3(2):e009769.
    [41] ACAMPA W, ASSANTE R, MANNARINO T, et al.Low-dose dynamic myocardial perfusion imaging by CZT-SPECT in the identification of obstructive coronary artery disease.Eur J Nucl Med Mol Imaging, 0,7(7):1705-1712.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

HAN Mengyue, XIE Feng, ZHU Fang, WU Tianhui, ZI Jinping, ZHOU Jinhui, CHEN Baiqing, WANG Wenjia. Diagnostic value and prospect of MBF and CFR measured by radionuclide myocardial imaging in coronary heart disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(3):260-264.

Copy
Related Videos

Share
Article Metrics
  • Abstract:903
  • PDF: 1049
  • HTML: 0
  • Cited by: 0
History
  • Received:October 24,2020
  • Revised:March 16,2021
  • Online: January 14,2022
Article QR Code

You are the visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025